WIRB-Copernicus Group Launches Non-Profit Foundation
WIRB-Copernicus Group® (WCG™), a provider of regulatory and ethical review services and software to support clinical research, announced the launch of WCG Foundation to strengthen protections for research participants and improve health and well-being worldwide.
WCG Foundation will initially focus on three programs: advancing education and training in research ethics at U.S. academic institutions, providing scholarships for the Western Institutional Review Board® (WIRB) International Fellows Program, and making IRB review more affordable for patients who are desperate to gain access to experimental treatments.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
